RNU7-102P

Across TCGA pan-cancer cohorts, RNU7-102P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNU7-102P data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher RNU7-102P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-102P expression acts as an unfavorable survival marker.

BRCA, OV, and GBM are the cancer types where RNU7-102P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Tertile	All	0.715	0.924	.040	18	view →
OV	DFS	Tertile	III,IV	0.241	0.380	.021	18	view →
GBM	DFS	Tertile	All	0.078	0.259	.009	18	view →
SARC	DFS	Tertile	All	0.167	0.552	.002	18	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNU7-102P–BRCA (OS)

Open the BRCA breakdown →